Evaluation of Myo-Inositol as a Potential Biomarker for Depression in Schizophrenia

Depression is highly prevalent in patients with schizophrenia and is associated with significant clinical consequences, but there is no known biomarker for depression in schizophrenia. One of the putative neurochemical biomarkers for depression in major depressive disorder (MDD) is reduced cerebral...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuropsychopharmacology
Main Authors: Chiappelli, Joshua, Rowland, Laura M, Wijtenburg, S Andrea, Muellerklein, Florian, Tagamets, Malle, McMahon, Robert P, Gaston, Frank, Kochunov, Peter, Hong, L Elliot
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2015
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4613604/
https://ncbi.nlm.nih.gov/pubmed/25722115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npp.2015.57
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados